Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Benefits of Remotely-Supervised Neuromodulation In Primary Progressive Aphasia

NCT07260253 is registered in ClinicalTrials.gov with Maya Henry as lead sponsor.

NCT NCT07260253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07260253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Benefits of Remotely-Supervised Neuromodulation In Primary Progressive Aphasia
Lead sponsor
Maya Henry
Phase
Not applicable
Overall status
Recruiting
Start date
April 15, 2026
Completion date
April 30, 2030
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

logopenic progressive aphasia (lpa), logopenic variant of primary progressive aphasia (lpa), logopenic variant primary progressive aphasia, primary progressive aphasia(ppa), progressive aphasia, progressive aphasia in alzheimer's disease